canopus biopharma inc (CBIA:OTC US)
canopus biopharma inc (CBIA) Snapshot
|
Open
--
|
Previous Close
$0.03
|
|
|
Day High
--
|
Day Low
--
|
|
|
52 Week High
06/27/12 - $0.26
|
52 Week Low
03/13/13 - $0.03
|
|
|
Market Cap
--
|
Average Volume 10 Days
0.0
|
|
|
EPS TTM
--
|
Shares Outstanding
0.0
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
canopus biopharma inc (CBIA) Related Businessweek News
No Related Businessweek News Foundcanopus biopharma inc (CBIA) Details
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Studio City, California.
| Recently Viewed | |||
| CBIA:US | $0.03 USD | 0.00 |  |
| Company | Last | Change | |
| No competitor information is available for CBIA. | |||
| View Industry Companies | |||
Industry Analysis
CBIA
Industry Average
| Valuation | CBIA | Industry Range |
| No financial data is available for CBIA. | ||
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact CANOPUS BIOPHARMA INC, please visit www.canopusbiopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
